| scholarly article | Q13442814 |
| P2093 | author name string | Lihua Wang | |
| Bing Shen | |||
| Xinyan Liu | |||
| Rongshan Li | |||
| Ya-Feng Li | |||
| Ying Jing | |||
| Xiaoshuang Zhou | |||
| Jielu Hao | |||
| Nathan C Frankfort | |||
| P2860 | cites work | miR-21 Gene expression triggered by AP-1 is sustained through a double-negative feedback mechanism | Q24316257 |
| HCV-induced miR-21 contributes to evasion of host immune system by targeting MyD88 and IRAK1 | Q24339505 | ||
| MicroRNA-320 is involved in the regulation of cardiac ischemia/reperfusion injury by targeting heat-shock protein 20 | Q24651483 | ||
| NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses | Q24670080 | ||
| Does AKI truly lead to CKD? | Q27024744 | ||
| Helical assembly in the MyD88–IRAK4–IRAK2 complex in TLR/IL-1R signalling | Q27661754 | ||
| Toll-like receptors | Q27860671 | ||
| Identification of tissue-specific microRNAs from mouse | Q27860892 | ||
| Switching from repression to activation: microRNAs can up-regulate translation | Q28131790 | ||
| MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells | Q28262214 | ||
| MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts | Q28511032 | ||
| Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21 | Q28975612 | ||
| The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling | Q29615457 | ||
| Ribo-gnome: the big world of small RNAs | Q29615681 | ||
| MicroRNAs: critical mediators of differentiation, development and disease | Q33786949 | ||
| Ischaemic preconditioning-regulated miR-21 protects heart against ischaemia/reperfusion injury via anti-apoptosis through its target PDCD4. | Q33997657 | ||
| Identification of a microRNA signature of renal ischemia reperfusion injury | Q34069581 | ||
| Pathophysiologic features and prevention of human and experimental acute tubular necrosis. | Q34184201 | ||
| Role of apoptosis of renal tubular cells in acute renal failure: therapeutic implications | Q34230683 | ||
| Type I interferon pathway mediates renal ischemia/reperfusion injury | Q34557372 | ||
| Increased circulating miR-21 levels are associated with kidney fibrosis. | Q34612770 | ||
| MicroRNA-21 is induced by rapamycin in a model of tuberous sclerosis (TSC) and lymphangioleiomyomatosis (LAM). | Q34652936 | ||
| MicroRNA-21 and risk of severe acute kidney injury and poor outcomes after adult cardiac surgery | Q34744060 | ||
| Intrinsic epithelial cells repair the kidney after injury | Q34765013 | ||
| miR-21: a small multi-faceted RNA. | Q34931601 | ||
| Gfi1 regulates miR-21 and miR-196b to control myelopoiesis | Q34961017 | ||
| Repair of injured proximal tubule does not involve specialized progenitors | Q35022127 | ||
| Recent advances in the pathophysiology of ischemic acute renal failure | Q35182393 | ||
| miR-21 contributes to xenon-conferred amelioration of renal ischemia-reperfusion injury in mice | Q35597122 | ||
| Ischemic acute renal failure: an inflammatory disease? | Q35836380 | ||
| Apoptosis and the target genes of microRNA-21. | Q35871493 | ||
| Biomarkers predict progression of acute kidney injury after cardiac surgery | Q35917512 | ||
| Expression, circulation, and excretion profile of microRNA-21, -155, and -18a following acute kidney injury | Q36401939 | ||
| Update on mechanisms of ischemic acute kidney injury | Q36481376 | ||
| The changing epidemiology of acute renal failure | Q36577185 | ||
| Smad7 suppresses renal fibrosis via altering expression of TGF-β/Smad3-regulated microRNAs | Q36673667 | ||
| Human Wharton's jelly-derived mesenchymal stromal cells reduce renal fibrosis through induction of native and foreign hepatocyte growth factor synthesis in injured tubular epithelial cells | Q36998033 | ||
| The innate immune response in ischemic acute kidney injury | Q37105485 | ||
| MicroRNAs: novel regulators in cardiac development and disease | Q37176880 | ||
| microRNAs and the immune response | Q37178538 | ||
| Delayed ischemic preconditioning contributes to renal protection by upregulation of miR-21 | Q37184698 | ||
| MicroRNAs as regulators of epithelial-mesenchymal transition. | Q37300965 | ||
| TIR-containing adaptors in Toll-like receptor signalling | Q37407517 | ||
| Recent insights into the structure of Toll-like receptors and post-translational modifications of their associated signalling proteins. | Q37559669 | ||
| Mediators of inflammation in acute kidney injury | Q37698228 | ||
| Regulation and function of miRNA-21 in health and disease. | Q37895431 | ||
| Pathophysiology of acute kidney injury to chronic kidney disease: maladaptive repair | Q37932961 | ||
| MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene | Q38292240 | ||
| MicroRNA-21 is overexpressed in renal cell carcinoma | Q39170988 | ||
| miR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes. | Q39215725 | ||
| An autoregulatory loop mediated by miR-21 and PDCD4 controls the AP-1 activity in RAS transformation | Q39930107 | ||
| Induction of in vitro reprogramming by Toll-like receptor (TLR)2 and TLR4 agonists in murine macrophages: effects of TLR "homotolerance" versus "heterotolerance" on NF-kappa B signaling pathway components | Q40681768 | ||
| Inhibition of apoptosis induced by ischemia-reperfusion prevents inflammation | Q40851731 | ||
| Plasma MicroRNAs as sensitive and specific biomarkers of tissue injury | Q43278313 | ||
| Sequential control of Toll-like receptor-dependent responses by IRAK1 and IRAK2. | Q50335834 | ||
| miR-21 downregulated TCF21 to inhibit KISS1 in renal cancer. | Q54280971 | ||
| A novel mechanism of NALP3 inducing ischemia reperfusion injury by activating MAPK pathway in acute renal failure. | Q54450685 | ||
| Effect of miR-21 on renal fibrosis by regulating MMP-9 and TIMP1 in kk-ay diabetic nephropathy mice | Q86207750 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | microRNA | Q310899 |
| pathogenesis | Q372016 | ||
| acute kidney injury | Q424337 | ||
| P304 | page(s) | 813-9 | |
| P577 | publication date | 2013-11-01 | |
| P1433 | published in | Protein & Cell | Q26854012 |
| P1476 | title | MicroRNA-21 in the pathogenesis of acute kidney injury | |
| P478 | volume | 4 |
| Q54975640 | Cadmium Nephrotoxicity Is Associated with Altered MicroRNA Expression in the Rat Renal Cortex. |
| Q42858165 | Can biomarkers of disease activity guide treatment in FSGS? |
| Q90434528 | Combining Extracellular miRNA Determination with Microfluidic 3D Cell Cultures for the Assessment of Nephrotoxicity: a Proof of Concept Study |
| Q27690667 | Current and emerging biomarkers of cell death in human disease. |
| Q37228202 | Detection of Drug-Induced Acute Kidney Injury in Humans Using Urinary KIM-1, miR-21, -200c, and -423 |
| Q38813338 | Differential expression of circulating miR-21, miR-142-3p and miR-155 in renal transplant recipients with impaired graft function. |
| Q53695024 | High circulatory leptin mediated NOX-2-peroxynitrite-miR21 axis activate mesangial cells and promotes renal inflammatory pathology in nonalcoholic fatty liver disease. |
| Q36688098 | Inhibiting microRNA-449 Attenuates Cisplatin-Induced Injury in NRK-52E Cells Possibly via Regulating the SIRT1/P53/BAX Pathway |
| Q52617937 | Ischaemia reperfusion injury: mechanisms of progression to chronic graft dysfunction. |
| Q38841304 | MiR-21 inhibits autophagy by targeting Rab11a in renal ischemia/reperfusion |
| Q40218788 | MicroRNA-21 (miR-21) expression in hypothermic machine perfusate may be predictive of early outcomes in kidney transplantation. |
| Q38820393 | MicroRNAs and drug-induced kidney injury |
| Q99555835 | MicroRNAs as Biomarkers and Therapeutic Targets in Inflammation- and Ischemia-Reperfusion-Related Acute Renal Injury |
| Q36057439 | Potential application of miRNAs as diagnostic and therapeutic tools in chronic pancreatitis |
| Q38191696 | Role of miR-21 and its signaling pathways in renal diseases |
| Q37233229 | Serum extracellular vesicular miR-21-5p is a predictor of the prognosis in idiopathic pulmonary fibrosis. |
| Q92840184 | Serum miRNA expression and correlation with clinical characteristics in acute kidney injury |
| Q54964308 | The Role of MicroRNAs in Kidney Disease. |
| Q28078393 | The potential use of biomarkers in predicting contrast-induced acute kidney injury |
| Q90258545 | miR-21 Protects Against Ischemia/Reperfusion-Induced Acute Kidney Injury by Preventing Epithelial Cell Apoptosis and Inhibiting Dendritic Cell Maturation |
| Q34790075 | miR-21 in ischemia/reperfusion injury: a double-edged sword? |
| Q58765739 | miR-214 ameliorates acute kidney injury via targeting DKK3 and activating of Wnt/β-catenin signaling pathway |
| Q38347455 | miRNAs in urine: a mirror image of kidney disease? |
| Q47811444 | miR‑21 attenuates contrast‑induced renal cell apoptosis by targeting PDCD4. |
| Q57458113 | microRNA-668 represses MTP18 to preserve mitochondrial dynamics in ischemic acute kidney injury |
Search more.